Results 111 to 120 of about 15,919 (234)

Costs and time spent by nurses and physicians during 3 months according to DOAC and VKA treatments.

open access: yes, 2023
Costs and time spent by nurses and physicians during 3 months according to DOAC and VKA treatments.
Sahondranirina Rakotoniary (15183119)   +17 more
core   +1 more source

Feasibility and Safety Profile of Non‐anesthesiologist‐administered Propofol During Colorectal Endoscopic Submucosal Dissection: A Single‐center Study of 454 Procedures

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Objectives Studies of non‐anesthesiologist‐administered propofol (NAAP) during colorectal endoscopic submucosal dissection (ESD) are scarce, particularly in the elderly. We evaluated its feasibility across a broad age range and identified factors associated with sedation‐related adverse events.
Yumi Kishi   +16 more
wiley   +1 more source

Analysis of patient adherence to treatment by DOAC IV. [PDF]

open access: yes
Analysis of patient adherence to treatment by DOAC IV Author: Leona Strnadová Tutor: PharmDr. Eliška Kolmanová, Ph.D. Consultant: PharmDr. Kateřina Malá, Ph.D.
Strnadová, Leona
core   +1 more source

An In Vitro Study Simulating Prophylactic Anticoagulation in Haemophilia A and B

open access: yeseJHaem, Volume 7, Issue 6, December 2026.
ABSTRACT Introduction Patients with haemophilia A (HA) and haemophilia B (HB) are at increased bleeding risk. A recent guidance document suggests considering pharmacological thromboprophylaxis on a case‐by‐case basis in these patients undergoing surgery at high‐risk of venous thromboembolism.
Nicoletta Riva   +8 more
wiley   +1 more source

Use of DOAC Stop Tablets in Coagulation Tests [PDF]

open access: yes, 2022
Předmětem této práce je popis metody neutralizace antikoagulační léčby přímými inhibitory koagulace (DOAC) pomocí DOAC stop tablet při in vitro použití.
Michaela Malíková
core  

A new strategy for monitoring of direct oral anticoagulants in patients with cyanotic and complex congenital heart disease

open access: yesInternational Journal of Cardiology Congenital Heart Disease
Background: Patients with congenital heart disease (CHD) often require an oral anticoagulation. Vitamin K antagonists (VKA) are the standard treatment, however, an increased hematocrit in patients with secondary erythrocytosis due to cyanosis complicates
Fabienne Dirbach   +5 more
doaj   +1 more source

Mobile health interventions to improve adherence to oral anticoagulant treatment: A systematic review and critical analysis

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 11, Page 3733-3758, November 2026.
Aims Non‐adherence to oral anticoagulants (OACs) is associated with significant morbidity and mortality. Mobile health (mHealth) interventions have been used to improve medication adherence across the three phases of initiation, implementation and persistence.
Non Davies   +2 more
wiley   +1 more source

Pharmacist Use of a Population Management Dashboard for Safe Anticoagulant Prescribing: Evaluation of a Nationwide Implementation Effort

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Direct oral anticoagulants (DOACs) have complex dosing regimens and are often incorrectly prescribed. We evaluated a nationwide DOAC population management dashboard rollout whose purpose includes pharmacist review and correction of off‐label ...
Geoffrey D. Barnes   +8 more
doaj   +1 more source

Efficacy and Safety of Apixaban Thromboprophylaxis According to Baseline Chemotherapy Class in High‐Risk Ambulatory Cancer Patients: A Post Hoc Analysis of the AVERT Trial

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Venous thromboembolism (VTE) is a leading cause of morbidity and mortality in cancer patients. The AVERT trial showed apixaban thromboprophylaxis reduced VTE in intermediate‐to‐high‐risk patients initiating chemotherapy. However, the efficacy and safety of apixaban according to baseline chemotherapy class remain incompletely ...
Nadia Linxi Feng   +10 more
wiley   +1 more source

Temporal Trends and Prognosis in Rotational Atherectomy: A Comparison of Contemporary and Traditional Eras

open access: yesCatheterization and Cardiovascular Interventions, Volume 108, Issue 5, Page 1828-1836, November 1, 2026.
ABSTRACT Background Rotational atherectomy (RA) has undergone considerable technical modernization in recent years. This study evaluated whether RA performed in the contemporary era was associated with superior cardiovascular outcomes compared with the traditional era. Aims To compare the clinical characteristics and cardiovascular outcomes of patients
Ravi Vazirani   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy